{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:33:37Z","timestamp":1793298817032,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.micpath.2025.107454","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:52:03Z","timestamp":1741827123000},"page":"107454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Combatting Acinetobacter baumannii pneumonia by multidrug codelivery of curcumin nanosuspensions and sulfamethoxazole with polymyxin B for targeted pediatric pulmonary inflammation and disease management"],"prefix":"10.1016","volume":"203","author":[{"given":"Jingjing","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3523-4363","authenticated-orcid":false,"given":"Xiaxia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.micpath.2025.107454_bib1","first-page":"992","article-title":"IN VIVO toxicity of nanoparticles : modalities and treatment","volume":"3","author":"Naseem","year":"2014"},{"key":"10.1016\/j.micpath.2025.107454_bib2","article-title":"WHO","volume":"1\u201323","author":"Caron","year":"2016","journal-title":"Pneumonia and Diarrhea: Tackling the Deadly Diseases of Children"},{"issue":"4","key":"10.1016\/j.micpath.2025.107454_bib3","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1007\/s13346-021-00954-1","article-title":"Nanoparticle-mediated pulmonary drug delivery: state of the art towards efficient treatment of recalcitrant respiratory tract bacterial infections","volume":"11","author":"Huang","year":"2021","journal-title":"Drug Delivery and Translational Research"},{"issue":"1","key":"10.1016\/j.micpath.2025.107454_bib4","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1080\/10717544.2022.2089294","article-title":"Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives","volume":"29","author":"Chen","year":"2022","journal-title":"Drug Deliv."},{"issue":"10","key":"10.1016\/j.micpath.2025.107454_bib5","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.clinthera.2013.08.003","article-title":"Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation study","volume":"35","author":"Stass","year":"2013","journal-title":"Clin. Ther."},{"key":"10.1016\/j.micpath.2025.107454_bib6","first-page":"1","volume":"2021","author":"Tsegaw","year":"2021","journal-title":"Predictors of Treatment Outcomes among Pediatric Patients Hospitalized with Pneumonia in Tikur Anbessa Specialized Hospital , Addis Ababa , Ethiopia"},{"issue":"1","key":"10.1016\/j.micpath.2025.107454_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-75218-y","article-title":"In vitro activity of biofilm inhibitors in combination with antibacterial drugs against extensively drug-resistant Acinetobacter baumannii","volume":"10","author":"Peng","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.micpath.2025.107454_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5152\/TurkArchPediatr.2024.23153","article-title":"Clinical reflections of acinetobacter infections in children in a quaternary-care hospital: a five-year single-center experience","volume":"59","author":"Elvan-T\u00fcz","year":"2024","journal-title":"Turkish Archives of Pediatrics"},{"issue":"1","key":"10.1016\/j.micpath.2025.107454_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s43094-023-00525-w","article-title":"Acinetobacter baumannii biofilm and its potential therapeutic targets","volume":"9","author":"Mohamed","year":"2023","journal-title":"Future Journal of Pharmaceutical Sciences"},{"issue":"November 2019","key":"10.1016\/j.micpath.2025.107454_bib10","article-title":"Enhanced anti-lung carcinoma and anti-biofilm activity of fungal molecules mediated biogenic zinc oxide nanoparticles conjugated with \u03b2-D-glucan from barley","volume":"203","author":"Saravanakumar","year":"2020","journal-title":"J. Photochem. Photobiol. B Biol."},{"issue":"5","key":"10.1016\/j.micpath.2025.107454_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051520","article-title":"Formulation strategies of nanosuspensions for various administration routes","volume":"15","author":"P\u0131nar","year":"2023","journal-title":"Pharmaceutics"},{"issue":"June","key":"10.1016\/j.micpath.2025.107454_bib12","article-title":"Redispersible nanosuspensions as a plausible oral delivery system for curcumin","volume":"121","author":"Elbaz","year":"2021","journal-title":"Food Hydrocoll."},{"issue":"September 2019","key":"10.1016\/j.micpath.2025.107454_bib13","article-title":"Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections","volume":"575","author":"Yu","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"August","key":"10.1016\/j.micpath.2025.107454_bib14","article-title":"Synergistic antibacterial effect of inhaled aztreonam and tobramycin fixed dose combination to combat multidrug-resistant Gram-negative bacteria","volume":"590","author":"Wang","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.micpath.2025.107454_bib15","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2147\/IDR.S169939","article-title":"Effectiveness and safety of polymyxin B for the treatment of infections caused by extensively drug-resistant gram-negative bacteria in Thailand","volume":"11","author":"Ngamprasertchai","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.micpath.2025.107454_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3635609","article-title":"Resurgence of polymyxin B for MDR\/XDR gram-negative infections: an overview of current evidence","volume":"2017","author":"Garg","year":"2017","journal-title":"Critical Care Research and Practice"},{"issue":"1","key":"10.1016\/j.micpath.2025.107454_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-020-05026-2","article-title":"Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis","volume":"20","author":"Lyu","year":"2020","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2025.107454_bib18","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3126\/bjhs.v5i1.29640","article-title":"Trimethoprim - sulfamethoxazole in combination with meropenem orpolymyxin is effective in management of acinetobacter baumannii associated pneumonia and urinary tract infection","volume":"5","author":"Keyal","year":"2020","journal-title":"Birat Journal of Health Sciences"},{"key":"10.1016\/j.micpath.2025.107454_bib19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2147\/IJN.S447429","article-title":"Nanosuspension-based drug delivery systems for topical applications","volume":"19","author":"Aldeeb","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.micpath.2025.107454_bib20","first-page":"1","article-title":"Development and evaluation of paclitaxel and curcumin dry powder for inhalation lung cancer treatment","volume":"13","author":"Lee","year":"2021","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.micpath.2025.107454_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/spectrum.01990-23","article-title":"Gut microbial dysbiosis occurring during pulmonary fungal infection in rats is linked to inflammation and depends on healthy microbiota composition","volume":"11","author":"Popovic","year":"2023","journal-title":"Microbiol. Spectr."},{"issue":"November 2022","key":"10.1016\/j.micpath.2025.107454_bib22","article-title":"Pulmonary multidrug codelivery of curcumin nanosuspensions and ciprofloxacin with N-acetylcysteine for lung infection therapy","volume":"84","author":"Liu","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"2","key":"10.1016\/j.micpath.2025.107454_bib23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jmii.2024.01.009","article-title":"Comparison of in vitro synergy between polymyxin B or colistin in combination with 16 antimicrobial agents against multidrug-resistant Acinetobacter baumannii isolates","volume":"57","author":"Wang","year":"2024","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"7","key":"10.1016\/j.micpath.2025.107454_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17719","article-title":"Associations of systemic inflammation markers with myocardial enzymes in pediatric adenotonsillar hypertrophy: a cross-sectional study","volume":"9","author":"Han","year":"2023","journal-title":"Heliyon"},{"issue":"August","key":"10.1016\/j.micpath.2025.107454_bib25","first-page":"1","article-title":"Crossm activity of cefiderocol alone and in combination with","volume":"9","author":"Polymyxin","year":"2020"},{"issue":"10","key":"10.1016\/j.micpath.2025.107454_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a025288","article-title":"Polymyxin: alternative mechanisms of action and resistance","volume":"6","author":"Trimble","year":"2016","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"8","key":"10.1016\/j.micpath.2025.107454_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/pr8080970","article-title":"Preparation of curcumin nanosuspension with gum Arabic as a natural stabilizer: process optimization and product characterization","volume":"8","author":"Duong","year":"2020","journal-title":"Processes"},{"issue":"February","key":"10.1016\/j.micpath.2025.107454_bib28","article-title":"Nanosuspensions technology as a master key for nature products drug delivery and in vivo fate","volume":"185","author":"Ma","year":"2023","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"January","key":"10.1016\/j.micpath.2025.107454_bib29","article-title":"Storage stability of inhalable, controlled-release powder formulations of ciprofloxacin nanocrystal-containing liposomes","volume":"605","author":"Khatib","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.micpath.2025.107454_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40824-020-0184-8","article-title":"Emerging role of nanosuspensions in drug delivery systems","volume":"24","author":"Jacob","year":"2020","journal-title":"Biomater. Res."},{"issue":"July 2021","key":"10.1016\/j.micpath.2025.107454_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejpb.2022.03.003","article-title":"A dual action of D-amino acids on anti-biofilm activity and moisture-protection of inhalable ciprofloxacin powders","volume":"173","author":"Chang","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.micpath.2025.107454_bib32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejpb.2019.08.004","article-title":"Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections","volume":"142","author":"Lin","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"November 2022","key":"10.1016\/j.micpath.2025.107454_bib33","article-title":"Development of spray-dried N-acetylcysteine dry powder for inhalation","volume":"631","author":"Mancini","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.micpath.2025.107454_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/B978-0-08-100382-4.00002-2","article-title":"Properties of biofilms developed on medical devices","author":"Puiu","year":"2017","journal-title":"Biofilms and Implantable Medical Devices: Infection and Control"},{"issue":"3","key":"10.1016\/j.micpath.2025.107454_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106889","article-title":"Impairment of novel non-coding small RNA00203 inhibits biofilm formation and reduces biofilm-specific antibiotic resistance in Acinetobacter baumannii","volume":"62","author":"Shenkutie","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"10","key":"10.1016\/j.micpath.2025.107454_bib36","article-title":"Antimicrobial and anti-biofilm peptide octominin for controlling multidrug-resistant acinetobacter baumannii","volume":"22","author":"Thulshan Jayathilaka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"July","key":"10.1016\/j.micpath.2025.107454_bib37","article-title":"Bovine skin fibroblasts mediated immune responses to defend against bovine Acinetobacter baumannii infection","volume":"173","author":"Hou","year":"2022","journal-title":"Microb. Pathog."},{"issue":"May","key":"10.1016\/j.micpath.2025.107454_bib38","first-page":"1","article-title":"Dihydroquercetin activates AMPK\/Nrf2\/HO-1 signaling in macrophages and attenuates inflammation in LPS-induced endotoxemic mice","volume":"11","author":"Lei","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107454_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-90208-4","article-title":"Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii","volume":"11","author":"Hetta","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.micpath.2025.107454_bib40","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/imm.12937","article-title":"Autoinflammatory disease in the lung","volume":"154","author":"Scambler","year":"2018","journal-title":"Immunology"},{"issue":"November 2022","key":"10.1016\/j.micpath.2025.107454_bib41","article-title":"Taxifolin ameliorates cigarette smoke-induced chronic obstructive pulmonary disease via inhibiting inflammation and apoptosis","volume":"115","author":"Liu","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"15","key":"10.1016\/j.micpath.2025.107454_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21155498","article-title":"Mechanisms protecting acinetobacter baumannii against multiple stresses triggered by the host immune response, antibiotics, and outside host environment","volume":"21","author":"Monem","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.micpath.2025.107454_bib43","article-title":"Pellino2 accelerate inflammation and pyroptosis via the ubiquitination and activation of NLRP3 inflammation in model of pediatric pneumonia","volume":"110","author":"Liu","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"June","key":"10.1016\/j.micpath.2025.107454_bib44","article-title":"Outer membrane protein A of Acinetobacter baumannii regulates pulmonary inflammation through the TLR2-NF-\u03baB pathway","volume":"284","author":"Li","year":"2023","journal-title":"Vet. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2025.107454_bib45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3748\/wjg.14.413","article-title":"Special issues in pediatric inflammatory bowel disease","volume":"14","author":"Dubinsky","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107454_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/20734735.0269-2020","article-title":"Inflammatory bowel disease and the lung in paediatric patients","volume":"17","author":"Jochmann","year":"2021","journal-title":"Breathe"},{"issue":"5","key":"10.1016\/j.micpath.2025.107454_bib47","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/1097-4628(20000801)77:5<1077::AID-APP15>3.0.CO;2-Q","article-title":"Graft copolymerization of vinyl monomers bearing positive charges or episulfide groups onto loofah fibers and their antibacterial activity","volume":"77","author":"Nonaka","year":"2000","journal-title":"J. Appl. Polym. Sci."},{"issue":"1","key":"10.1016\/j.micpath.2025.107454_bib48","first-page":"1","article-title":"Histopathological changes caused by inflammation and oxidative stress in diet-induced-obese mouse following experimental lung injury","volume":"8","author":"Wang","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.micpath.2025.107454_bib49","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1183\/09031936.00093911","article-title":"Resolution of acute lung injury and inflammation: a translational mouse model","volume":"39","author":"Patel","year":"2012","journal-title":"Eur. Respir. J."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025001792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025001792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:27:10Z","timestamp":1744259230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025001792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":49,"alternative-id":["S0882401025001792"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107454","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combatting Acinetobacter baumannii pneumonia by multidrug codelivery of curcumin nanosuspensions and sulfamethoxazole with polymyxin B for targeted pediatric pulmonary inflammation and disease management","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107454"}}